Literature DB >> 16598177

Pathogenicity of fowl adenovirus isolated from gizzard erosions to immuno-suppressed chickens.

Norihiko Muroga1, Satoshi Taharaguchi, Hideyuki Ohta, Ken-Ichi Yamazaki, Kozo Takase.   

Abstract

Pathogenicity of a fowl adenovirus (FAV), JM1/1 strain of serotype 1 derived from gizzard erosions of a broiler chicken, was examined to specific pathogen-free (SPF) chickens pre-treated with infectious bursal disease viruses (IBDVs) or cyclophosphamide (CY). Virulent IBDVs, classical type, were inoculated orally at 3 days of age of SPF chickens. CY was treated subcutaneously for 3 days after hatch. FAV was given orally at 30 days of age. At 40 days of age, all chickens were bled and autopsied for serology and gross observation. Gizzard lesions were ranked by the scores depending on their severities. IBDV- or CY-treated chickens showed significantly higher gizzard lesion scores than non treated birds. There were no gross lesions in any other organs except for bursal atrophy. Serologically, antibody production against FAV was highly suppressed by IBDV infection or CY treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598177     DOI: 10.1292/jvms.68.289

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Classification of fowl adenovirus serotypes by use of high-resolution melting-curve analysis of the hexon gene region.

Authors:  Penelope A Steer; Naomi C Kirkpatrick; Denise O'Rourke; Amir H Noormohammadi
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

2.  Quantity of virulent fowl adenovirus serotype 1 correlates with clinical signs, macroscopical and pathohistological lesions in gizzards following experimental induction of gizzard erosion in broilers.

Authors:  Beatrice Grafl; Dieter Liebhart; Ayse Günes; Patricia Wernsdorf; Franz Aigner; Josef Bachmeier; Michael Hess
Journal:  Vet Res       Date:  2013-05-24       Impact factor: 3.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.